Log In
BCIQ
Print this Print this
 

VSV-GP

  Manage Alerts
Collapse Summary General Information
Company ViraTherapeutics GmbH
DescriptionChimeric virus that carries the surface protein from the lymphocytic choriomeningitis virus (LCMV)
Molecular Target
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerBoehringer Ingelheim GmbH

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/28/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today